PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHemorrhoids
MeSH D006484 - hemorrhoids
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012002:Rectal diseases
0 Companies
0 Drugs
Success rate
D014652:Vascular diseases
$
Success rate
D006484: 
Hemorrhoids
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsHydrocortisone Anusol  1984-06-06   
TevaHydrocortisone Hydrocortisone  1994-05-27   
Hydrocortisone Nogenic  1988-04-04   
PadagisHydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Hydrocortisone Hydrocortisone  2000-05-24   
Hydrocortisone Stie-cort  1985-11-25   
Taro PharmaceuticalHydrocortisone Hydrocortisone  1999-07-23   
Hydrocortisone Hydrocortisone Acetic Acid  1985-03-04   
Hydrocortisone butyrate Hydrocortisone Butyrate  2004-01-14   
Hydrocortisone U-cort  1988-06-13   
Glenmark PharmaceuticalsHydrocortisone Hydrocortisone  2018-10-12   
Hydrocortisone butyrate Hydrocortisone Butyrate  2013-09-27   
MylanHydrocortisone Cortifoam  1982-02-10   
Hydrocortisone, Pramoxine Epifoam  1982-01-01   
Hydrocortisone, Pramoxine Proctofoam  1982-01-01   
PerrigoHydrocortisone Hydrocortisone  1982-01-01   
Ibuprofen, Phenylephrine Ibuprofen Phenylephrine  2014-07-03   
GSKIbuprofen, Phenylephrine, Chlorpheniramine Advil  2011-12-21   
Lupin ResearchHydrocortisone Hydrocortisone  2019-08-15   
Hydrocortisone butyrate Hydrocortisone Butyrate  2018-08-17   
Phenylephrine, Ketorolac tromethamine Ketorolac Tromethamine Phenylephrine  2019-07-01   
SandozHydrocortisone Hydrocortisone  1982-01-01   
Hydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  1983-08-25   
Phenylephrine Phenylephrine  2019-01-31   
Hydrocortisone, Ciprofloxacin Cipro  1998-02-10   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
86%
6/7
Phase 2
58%
7/12
Phase 3
76%
13/17
Approved: 6Overall Success rate: 38%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Perrigo
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use